Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2017-08-01

FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)

View source ↗

Summary

FDA approved a supplemental application for Lubiprostone filed by Dr. Reddy's Laboratories to update the product labeling with expanded indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUBIPROSTONE (lubiprostone)

Snippet

SUPPL AP for LUBIPROSTONE (LUBIPROSTONE)